No Data
Zhengchuan Co., Ltd.: 2024 Annual Report
Zhengchuan Co., Ltd.: 2024 Annual Report Summary
2024 ANNUAL REPORT
2024 Annual Report Summary
Chongqing Zhengchuan Pharmaceutical Packaging (603976.SH): The net income for 2024 is 53.2488 million yuan, a year-on-year increase of 32.24%.
On April 9, Gelonghui reported that Chongqing Zhengchuan Pharmaceutical Packaging (603976.SH) released its 2024 annual report, during which it achieved revenue of 0.801 billion yuan, a year-on-year decrease of 11.05%; the net income attributable to the shareholders of the listed company was 53.2488 million yuan, an increase of 32.24% year-on-year; the basic EPS was 0.35 yuan. It is proposed to distribute a cash dividend of 2.46 yuan (including tax) for every 10 shares to all shareholders.
Debon Securities: The scale of borosilicate pharmaceutical glass is continuously expanding. Pay attention to the improvement in profitability within the industry as costs decline.
National centralized procurement promotes the adoption of pharmaceuticals with medium borosilicate packaging, expanding the market size of medium borosilicate pharmaceutical glass.